PedAM
Pediatric Disease Annotations & Medicines
| Disease | glioma |
| Symptom | C0021079|immunosuppression |
| Sentences | 4 |
| PubMedID- 22932670 | Thus, the data suggest a critical role for ido-mediated immunosuppression in glioma and support the continued investigation of ido-treg interactions in the context of brain tumors. |
| PubMedID- 26378585 | These data suggest a critical role for ido1-mediated immunosuppression in glioma and support the continued investigation of ido-treg interactions in the context of the suppression of brain tumor outgrowth. |
| PubMedID- 24582432 | Due to the poor prognosis associated with immunosuppression in glioma patients, tregs remain a promising area for immunotherapeutic research. |
| PubMedID- 21725605 | Transforming growth factor (tgf)-beta2 is a mediator of immunosuppression associated with malignant glioma and also influences pro-invasive functions. |
Page: 1